🔎 Trials Near Me

Beranda › Tumor Wilms › Distrik Columbia › Washington

Uji klinis Tumor Wilms di Washington, DC

7 studi untuk Tumor Wilms mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Menerima pesertaFase 2
  • Children's National Medical Center, Washington D.C.
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT04616560

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Menerima pesertaFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Menerima pesertaFase 2
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
Hingga usia 30 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04322318

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Menerima pesertaFase 1
  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Usia 1 hingga 23 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07172958

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Menerima pesertaFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT04901702

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

Menerima pesertaFase 2
  • Children's National Hospital (Data Collection Only), Washington D.C.
12 Months · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT05985161

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Menerima pesertaFase 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT05135975

Uji klinis Tumor Wilms di kota lain

Studi lain di Washington

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.